Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Transplantation

  Free Subscription

Articles published in J Hepatol

Retrieve available abstracts of 68 articles:
HTML format

Single Articles

    November 2021
  1. RAVAIOLI M, Lai Q, Sessa M, Ghinolfi D, et al
    Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    J Hepatol. 2021 Nov 10. pii: S0168-8278(21)02166.
    PubMed     Abstract available

    October 2021
  2. SCHLEGEL A, van Reeven M, Croome K, Parente A, et al
    A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation.
    J Hepatol. 2021 Oct 13. pii: S0168-8278(21)02110.
    PubMed     Abstract available

  3. RUSSO FP, Izzy M, Rammohan A, Kirchner VA, et al
    Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).
    J Hepatol. 2021 Oct 12. pii: S0168-8278(21)02107.
    PubMed     Abstract available

  4. RABINOWICH L, Shibolet O, Katchman H
    Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: time for comprehensive data analysis.
    J Hepatol. 2021 Oct 8. pii: S0168-8278(21)02102.

  5. MALLET V, Beeker N, Bouam S, Sogni P, et al
    Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.
    J Hepatol. 2021;75:848-855.
    PubMed     Abstract available

    September 2021
  6. ARTRU F, le Goffic C, Pageaux GP, Saliba F, et al
    Sarcopenia should be evaluated in patients with acute-on-chronic liver failure and candidates to liver transplantation.
    J Hepatol. 2021 Sep 15. pii: S0168-8278(21)02034.

  7. AGOPIAN VG, Markovic D
    Reply to: correspondence regarding "Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction".
    J Hepatol. 2021;75:732-735.

  8. EEROLA V, Aberg F, Sallinen V
    An unequivocal formula to calculate L-GrAFT score is needed.
    J Hepatol. 2021;75:731-732.

    August 2021
  9. THULUVATH PJ, Robarts P, Chauhan M
    Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    J Hepatol. 2021 Aug 26. pii: S0168-8278(21)02002.
    PubMed     Abstract available

  10. VIONNET J, Miquel R, Abraldes JG, Wall J, et al
    Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
    J Hepatol. 2021 Aug 23. pii: S0168-8278(21)02001.
    PubMed     Abstract available

  11. GUARINO M, Cossiga V, Esposito I, Alessandro F, et al
    Effectiveness of SARS-Cov-2 vaccination in liver transplanted patients: the debate is open!
    J Hepatol. 2021 Aug 3. pii: S0168-8278(21)01961.

    July 2021
  12. PENRICE DD, Havlichek D 3rd, Kamath PS, Simonetto DA, et al
    Outcomes Following Liver Transplant in Adults with Telomere Biology Disorders.
    J Hepatol. 2021 Jul 28. pii: S0168-8278(21)01951.

  13. BETTINGER D, Thimme R, Schultheiss M
    Reply: TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 Jul 6. pii: S0168-8278(21)01891.

  14. BURRA P, Samuel D, Sundaram V, Duvoux C, et al
    Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.
    J Hepatol. 2021;75 Suppl 1:S178-S190.
    PubMed     Abstract available

    June 2021
  15. RELA M, Rammohan A
    Why Are There So Many Liver Transplants from Living Donors In Asia And So Few In Europe And The US?
    J Hepatol. 2021 Jun 7. pii: S0168-8278(21)00408.
    PubMed     Abstract available

    May 2021
    Early liver transplantation for acute alcoholic hepatitis: we can't say no.
    J Hepatol. 2021 May 28. pii: S0168-8278(21)00354.
    PubMed     Abstract available

  17. GIANNINI EG, Marenco S
    High acceptance rate of COVID-19 vaccination in liver transplant recipients.
    J Hepatol. 2021 May 27. pii: S0168-8278(21)00344.

  18. RUDLER M, Savier E, Alioua I, Sultanik P, et al
    TIPS and liver transplantation should always be discussed together.
    J Hepatol. 2021 May 26. pii: S0168-8278(21)00347.

  19. CORNBERG M, Eberhardt CS
    Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.
    J Hepatol. 2021 May 25. pii: S0168-8278(21)00342.

  20. DE GASPERI A, Zorzi A
    Cardiac evaluation before liver transplantation: a step forward?
    J Hepatol. 2021 May 10. pii: S0168-8278(21)00299.

    April 2021
  21. BELLI LS, Duvoux C, Artzner T, Bernal W, et al
    Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS).
    J Hepatol. 2021 Apr 24. pii: S0168-8278(21)00261.
    PubMed     Abstract available

  22. RABINOWICH L, Grupper A, Baruch R, Ben-Yehoyada M, et al
    Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.
    J Hepatol. 2021 Apr 20. pii: S0168-8278(21)00255.
    PubMed     Abstract available

  23. RODRIGUEZ-PERALVAREZ M, Colmenero J, Salcedo M
    Reply to: Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.
    J Hepatol. 2021 Apr 13. pii: S0168-8278(21)00239.

    March 2021
  24. POSE E, Torrents A, Reverter E, Perez-Campuzano V, et al
    A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement.
    J Hepatol. 2021 Mar 18. pii: S0168-8278(21)00175.
    PubMed     Abstract available

    February 2021
  25. CORNBERG M, Buti M, Eberhardt CS, Grossi PA, et al
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    J Hepatol. 2021 Feb 6. pii: S0168-8278(21)00081.
    PubMed     Abstract available

  26. WEBB GJ, Moon AM, Barnes E, Barritt AS 4th, et al
    Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients.
    J Hepatol. 2021 Feb 5. pii: S0168-8278(21)00085.

    January 2021
  27. DE MARTIN E, Coilly A, Chazouilleres O, Roux O, et al
    Early liver transplantation for corticosteroid non-responders in acute severe autoimmune hepatitis: the SURFASA score.
    J Hepatol. 2021 Jan 24. pii: S0168-8278(21)00041.
    PubMed     Abstract available

  28. RACHWAN RJ, Kutkut I, Timsina LR, Bou Chaaya RG, et al
    CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
    J Hepatol. 2021 Jan 18. pii: S0168-8278(21)00016.
    PubMed     Abstract available

  29. RAHIM MN, Theocharidou E, Yen Lau KG, Ahmed R, et al
    Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients.
    J Hepatol. 2021 Jan 15. pii: S0168-8278(21)00005.
    PubMed     Abstract available

  30. GOLDBERG D, Mantero A, Newcomb C, Delgado C, et al
    Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score.
    J Hepatol. 2021 Jan 13. pii: S0168-8278(21)00004.
    PubMed     Abstract available

    December 2020
  31. AVOLIO AW, Lai Q, Cillo U, Romagnoli R, et al
    L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores.
    J Hepatol. 2020 Dec 16. pii: S0168-8278(20)33848.

  32. MANKA P, Canbay A, Bechmann LP
    Model for end-stage liver disease-sodium in acute-on-chronic liver failure.
    J Hepatol. 2020;73:1578-1579.

    August 2020

  33. EASL recommendations on treatment of hepatitis C - Final update of the series.
    J Hepatol. 2020 Aug 21. pii: S0168-8278(20)30548.
    PubMed     Abstract available

  34. YOSHIZUMI T, Itoh S, Shimokawa M, Inokuchi S, et al
    Simultaneous splenectomy improves outcomes after adult living donor liver transplantation.
    J Hepatol. 2020 Aug 19. pii: S0168-8278(20)30547.
    PubMed     Abstract available

  35. LINE PD, Dueland S
    Liver transplantation for secondary liver tumors: the difficult balance between survival and recurrence.
    J Hepatol. 2020 Aug 17. pii: S0168-8278(20)30539.

  36. COLMENERO J, Rodriguez-Peralvarez M, Salcedo M, Arias-Milla A, et al
    Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.
    J Hepatol. 2020 Aug 1. pii: S0168-8278(20)30521.
    PubMed     Abstract available

    July 2020
  37. VERNA EC, Akushevich L, Vainorius M, Fried MW, et al
    Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients with a liver transplant perspective?"
    J Hepatol. 2020 Jul 15. pii: S0168-8278(20)30386.

  38. MEUNIER L, Pageaux GP, Coilly A
    HCV treatment in cirrhotic patients: Should we use a different approach for patients with a liver transplant perspective?
    J Hepatol. 2020 Jul 8. pii: S0168-8278(20)30345.

    June 2020
  39. PAPATHEODORIDIS GV, Dalekos GN, Idilman R, Sypsa V, et al
    Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
    J Hepatol. 2020 Jun 15. pii: S0168-8278(20)30382.
    PubMed     Abstract available

    May 2020
  40. CHEW CA, Iyer SG, Chieh Kow AW, Madhavan K, et al
    An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise.
    J Hepatol. 2020 May 23. pii: S0168-8278(20)30342.
    PubMed     Abstract available

  41. GULFO J, Rotondo F, de Leon CGA, Cornide-Petronio ME, et al
    FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
    J Hepatol. 2020 May 15. pii: S0168-8278(20)30299.
    PubMed     Abstract available

  42. STATTERMAYER AF, Halilbasic E, Wrba F, Ferenci P, et al
    Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    J Hepatol. 2020 May 3. pii: S0168-8278(20)30280.
    PubMed     Abstract available

    April 2020
  43. MAZUMDER NR, Celaj S, Atiemo K, Daud A, et al
    Liver-related mortality is similar among men and women with cirrhosis.
    J Hepatol. 2020 Apr 25. pii: S0168-8278(20)30235.
    PubMed     Abstract available

  44. CORPECHOT C, Chazouilleres O, Belnou P, Montano-Loza AJ, et al
    Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
    J Hepatol. 2020 Apr 7. pii: S0168-8278(20)30205.
    PubMed     Abstract available

    March 2020
  45. VERNA EC, Morelli G, Terrault NA, Lok AS, et al
    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    J Hepatol. 2020 Mar 31. pii: S0168-8278(20)30193.
    PubMed     Abstract available

  46. LAI JC, Dodge JL, Kappus MR, Dunn MA, et al
    Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    J Hepatol. 2020 Mar 30. pii: S0168-8278(20)30191.
    PubMed     Abstract available

  47. CUCCHETTI A, Serenari M, Sposito C, Di Sandro S, et al
    Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
    J Hepatol. 2020 Mar 19. pii: S0168-8278(20)30177.
    PubMed     Abstract available

  48. SAVALE L, Guimas M, Ebstein N, Fertin M, et al
    Portopulmonary hypertension in the current era of pulmonary hypertension management.
    J Hepatol. 2020 Mar 4. pii: S0168-8278(20)30119.
    PubMed     Abstract available

    February 2020
  49. MAZZAFERRO V, Gorgen A, Roayaie S, Droz Dit Busset M, et al
    Liver resection and transplantation for intrahepatic cholangiocarcinoma.
    J Hepatol. 2020;72:364-377.
    PubMed     Abstract available

  50. VIBERT E, Schwartz M, Olthoff KM
    Advances in resection and transplantation for hepatocellular carcinoma.
    J Hepatol. 2020;72:262-276.
    PubMed     Abstract available

    January 2020
  51. IKEGAMI T, Yoshizumi T, Tomiyama T, Inokuchi S, et al
    Extensive portal thrombectomy with secure shunt ligation should be more strongly emphasized in the real-world setting.
    J Hepatol. 2020;72:199-201.

    October 2019
  52. SUNDARAM V, Kogachi S, Wong RJ, Karvellas CJ, et al
    Effect of the clinical course of acute on chronic liver failure prior to liver transplantation on post-transplant survival.
    J Hepatol. 2019 Oct 25. pii: S0168-8278(19)30640.
    PubMed     Abstract available

  53. GIANNELLI V, Roux O, Laouenan C, Manchon P, et al
    Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
    J Hepatol. 2019 Oct 14. pii: S0168-8278(19)30603.
    PubMed     Abstract available

    September 2019
  54. DUVOUX C
    Anonymous living donation in liver transplantation: Squaring the circle or condemned to vanish?
    J Hepatol. 2019 Sep 24. pii: S0168-8278(19)30522.

    July 2019
  55. GOET JC, Floreani A, Verhelst X, Cazzagon N, et al
    Validation, Clinical Utility and Limitations of the Amsterdam-Oxford Model for Primary Sclerosing Cholangitis.
    J Hepatol. 2019 Jul 3. pii: S0168-8278(19)30384.
    PubMed     Abstract available

    June 2019
  56. LIU Y, Lu T, Zhang C, Xu J, et al
    Activation of YAP Attenuates Hepatic Damage and Fibrosis in Liver Ischemia-Reperfusion Injury.
    J Hepatol. 2019 Jun 12. pii: S0168-8278(19)30344.
    PubMed     Abstract available

    May 2019
  57. FONTANELLAS A, Avila MA, Anderson KE, Deybach JC, et al
    Current and innovative emerging therapies for porphyrias with hepatic involvement.
    J Hepatol. 2019 May 15. pii: S0168-8278(19)30282.
    PubMed     Abstract available

  58. JI F, Yeo YH, Wei MT, Ogawa E, et al
    Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.
    J Hepatol. 2019 May 13. pii: S0168-8278(19)30279.
    PubMed     Abstract available

    April 2019
  59. MOUNA L, Rossignol E, Tateo M, Coilly A, et al
    Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.
    J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30136.

  60. KIM SU, Seo YS, Lee HA, Kim MN, et al
    A multi-center study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in the Republic of Korea.
    J Hepatol. 2019 Apr 5. pii: S0168-8278(19)30222.
    PubMed     Abstract available

    March 2019
  61. NAHON P, Soubrane O
    Fa(s)t assessment of the liver graft: Is it relevant?
    J Hepatol. 2019;70:346-347.

    January 2019
  62. SOLA E, Sole C, Gines P
    Reply to: "Midodrine and albumin in decompensated cirrhosis: Down but not out...".
    J Hepatol. 2019 Jan 30. pii: S0168-8278(18)32646.

  63. SINGH V, Singh A, Agarwal R
    Midodrine and albumin in decompensated cirrhosis: Down but not out....
    J Hepatol. 2019 Jan 23. pii: S0168-8278(18)32540.

  64. DOYLE A, Gorgen A, Muaddi H, Aravinthan AD, et al
    Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.
    J Hepatol. 2019 Jan 4. pii: S0168-8278(19)30001.
    PubMed     Abstract available

    November 2018
  65. MODIN L, Arshad A, Wilkes B, Benselin J, et al
    Epidemiology and natural history of hepatitis C virus infection among children and young people.
    J Hepatol. 2018 Nov 26. pii: S0168-8278(18)32545.
    PubMed     Abstract available

    September 2018
  66. GUSTOT T, Moreau R
    Acute-on-Chronic Liver Failure vs. Traditional Acute Decompensation of Cirrhosis.
    J Hepatol. 2018 Sep 6. pii: S0168-8278(18)32370.
    PubMed     Abstract available

    July 2018
  67. AJI T, Dong JH, Shao YM, Zhao JM, et al
    Ex vivo Liver Resection and Autotransplantation as Alternative to Allotransplantation for End-stage Hepatic Alveolar Echinococcosis.
    J Hepatol. 2018 Jul 19. pii: S0168-8278(18)32258.
    PubMed     Abstract available

    June 2018
  68. FUHRMANN V, Krowka M
    Hepatopulmonary syndrome.
    J Hepatol. 2018 Jun 27. pii: S0168-8278(18)30007.

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.